PL2539352T3 - Pochodne amp do leczenia chorób serca - Google Patents

Pochodne amp do leczenia chorób serca

Info

Publication number
PL2539352T3
PL2539352T3 PL11713395T PL11713395T PL2539352T3 PL 2539352 T3 PL2539352 T3 PL 2539352T3 PL 11713395 T PL11713395 T PL 11713395T PL 11713395 T PL11713395 T PL 11713395T PL 2539352 T3 PL2539352 T3 PL 2539352T3
Authority
PL
Poland
Prior art keywords
treating cardiac
cardiac diseases
amp derivatives
derivatives
diseases
Prior art date
Application number
PL11713395T
Other languages
English (en)
Inventor
Bruce Liang
Kenneth A. Jacobson
Bhalchandra V. Joshi
Thatikonda Santosh Kumar
Original Assignee
University Of Connecticut
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Connecticut, The United States Of America, As Represented By The Secretary, Department Of Health And Human Services filed Critical University Of Connecticut
Publication of PL2539352T3 publication Critical patent/PL2539352T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11713395T 2010-02-22 2011-02-22 Pochodne amp do leczenia chorób serca PL2539352T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30668710P 2010-02-22 2010-02-22
EP11713395.9A EP2539352B1 (en) 2010-02-22 2011-02-22 Amp derivatives for treating cardiac diseases
PCT/US2011/025680 WO2011103552A2 (en) 2010-02-22 2011-02-22 Compositions and methods to treat cardiac diseases

Publications (1)

Publication Number Publication Date
PL2539352T3 true PL2539352T3 (pl) 2018-03-30

Family

ID=44212109

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11713395T PL2539352T3 (pl) 2010-02-22 2011-02-22 Pochodne amp do leczenia chorób serca

Country Status (11)

Country Link
US (3) US8822434B2 (pl)
EP (1) EP2539352B1 (pl)
CN (1) CN102985432B (pl)
AU (1) AU2011217815B2 (pl)
CA (1) CA2789259C (pl)
DK (1) DK2539352T3 (pl)
ES (1) ES2654363T3 (pl)
HU (1) HUE037611T2 (pl)
PL (1) PL2539352T3 (pl)
PT (1) PT2539352T (pl)
WO (1) WO2011103552A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8822434B2 (en) 2010-02-22 2014-09-02 The University Of Connecticut Compositions and methods to treat cardiac diseases
KR102119354B1 (ko) 2016-01-29 2020-06-04 가부시키가이샤 한도오따이 에네루기 켄큐쇼 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
EP3445368B1 (en) 2016-04-21 2024-07-17 Astrocyte Pharmaceuticals, Inc. Compounds and methods for treating neurological and cardiovascular conditions
TWI909429B (zh) 2016-09-14 2025-12-21 日商半導體能源研究所股份有限公司 有機化合物、發光元件、發光裝置、電子裝置及照明設備
KR102701648B1 (ko) 2016-12-28 2024-09-03 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 표시 장치, 및 조명 장치
CN110896635B (zh) 2017-05-02 2023-11-03 株式会社半导体能源研究所 有机化合物、发光元件、发光装置、电子设备及照明装置
CN112218638A (zh) 2018-02-09 2021-01-12 阿斯特罗赛特制药公司 用于治疗成瘾和相关病症的化合物和方法
KR102802338B1 (ko) 2018-05-31 2025-04-29 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
KR102855273B1 (ko) 2018-07-31 2025-09-05 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
EP3856741A4 (en) 2018-09-26 2022-06-22 Astrocyte Pharmaceuticals, Inc. POLYMORPHOUS COMPOUNDS AND USES THEREOF
CN116173046B (zh) * 2023-03-29 2025-03-18 南京医科大学 一种天然小分子Peli1抑制剂
US20250049710A1 (en) * 2023-07-21 2025-02-13 Comovus Pharmaceuticals, Inc. Aqueous formulations of a cardiac p2x receptor agonist and their use in treating medical disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7348315B2 (en) * 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
US5712258A (en) * 1995-03-23 1998-01-27 The Trustees Of The University Of Pennsylvania Inotropic ADP and ATP analogues and their pharmaceutical compositions
AU1363699A (en) * 1997-10-23 1999-05-10 National Institute Of Health Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents
US6677356B1 (en) * 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6586413B2 (en) * 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
US7087589B2 (en) * 2000-01-14 2006-08-08 The United States Of America As Represented By The Department Of Health And Human Services Methanocarba cycloakyl nucleoside analogues
JP2008512457A (ja) 2004-09-09 2008-04-24 アメリカ合衆国 Ａ３及びａ１アデノシン受容体作用薬としてのプリン誘導体
WO2006091905A1 (en) 2005-02-25 2006-08-31 Gilead Sciences, Inc. Bicyclo (3.1.0) hexane derivatives as antiviral compounds
EP2049127B1 (en) * 2006-05-23 2014-11-26 University of Connecticut N-methanocarba derivatives to treat cardiac diseases
US8822434B2 (en) 2010-02-22 2014-09-02 The University Of Connecticut Compositions and methods to treat cardiac diseases

Also Published As

Publication number Publication date
CN102985432B (zh) 2016-11-02
WO2011103552A2 (en) 2011-08-25
ES2654363T3 (es) 2018-02-13
WO2011103552A3 (en) 2012-03-15
US20150038463A1 (en) 2015-02-05
HUE037611T2 (hu) 2018-09-28
CA2789259C (en) 2019-08-20
DK2539352T3 (en) 2018-01-08
EP2539352A2 (en) 2013-01-02
PT2539352T (pt) 2018-01-03
WO2011103552A9 (en) 2012-04-26
AU2011217815B2 (en) 2015-03-12
CN102985432A (zh) 2013-03-20
US8822434B2 (en) 2014-09-02
EP2539352B1 (en) 2017-10-04
US9303053B2 (en) 2016-04-05
CA2789259A1 (en) 2011-08-25
US9526739B2 (en) 2016-12-27
US20160166591A1 (en) 2016-06-16
AU2011217815A1 (en) 2012-10-11
US20110212924A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
PL2539352T3 (pl) Pochodne amp do leczenia chorób serca
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
ZA201308417B (en) Tissue healing
PL2643004T3 (pl) Kompozycja oligosacharydów do leczenia chorób skóry
IL220876A0 (en) Treatment of cardiac conditions
ZA201301601B (en) Treatment of diseases
IL275350B (en) Treatment of neoplastic diseases
GB2496805B (en) Compounds for photodynamic therapy
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
EP2621498A4 (en) COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
IL231185B (en) Biocompatible catheter
IL225755A0 (en) Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain
PL392436A1 (pl) Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
EP2601954A4 (en) THERAPEUTIC FOR DISEASES
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
ZA201308176B (en) Therapeutic treatment
ZA201400488B (en) Compounds for the treatment of cancers associated with human papillomavirus
GB201016836D0 (en) Composition for skin treatment
GB201016834D0 (en) Composition for skin treatment
HUE048942T2 (hu) Antraciklin-származékok tumorbetegségek kezeléséhez
GB201009094D0 (en) Compounds for the treatment of closridium difficile-associated disease
GB201110659D0 (en) composition for skin treatment
GB201110653D0 (en) Composition for skin treatment
GB201019034D0 (en) Treatment for tumors
HK1188955A (en) Methods for treating diseases of the retina